Bionano Genomics (BNGO) revenue and earnings history
Bionano Genomics reported revenue of $28.5M for fiscal 2025 (year ended Dec 31, 2025), −7.4% on the year before, and net income of −$26.4M.
Over 8 years, from fiscal 2017 to fiscal 2025, revenue grew at a compound rate of +14.7% a year.
Revenue and net income, 9 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $28.5M−7.4% | −$33.3M | −$26.4M | −$16.3M | — | — | $4.53M | — | — | $2.99M | — | 10-K |
| 2024ended Dec 31, 2024 |
The latest quarter, insider trades and fund moves: Bionano Genomics (BNGO) on OQRO.
Common questions
What was Bionano Genomics's revenue in fiscal 2025?
$28.5M for the year ended Dec 31, 2025, as reported in its 10-K filed Mar 23, 2026. That is −7.4% on fiscal 2024 ($30.8M).
How fast has Bionano Genomics's revenue grown?
From $9.51M in fiscal 2017 to $28.5M in fiscal 2025: a compound annual growth rate of +14.7% over 8 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Has Bionano Genomics been profitable?
It reported a net loss in 9 of the years shown (2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025). The highest net income was −$18.5M in fiscal 2018.
Where these figures come from
The SEC’s companyfacts data: every figure Bionano Genomics tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
